Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2013

Open Access 01-12-2013 | Primary research

Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma

Authors: Song Zhang, Shuo Li, Jin-Liang Gao

Published in: Cancer Cell International | Issue 1/2013

Login to get access

Abstract

Background

The transcription factor SOX11 is one of members of the SRY box-containing (SOX) family emerging as important transcriptional regulators. In recent years, up-regulation of SOX11 has been detected in various types of solid tumors. In this study, the effects of promoter methylation of the SOX11 gene on SOX11 expression and cell growth and invasion of nasopharyngeal carcinoma were investigated.

Methods

In this study,methylation-specific PCR and real time quantitative PCR have been applied to investigate the effect of promoter methylation of the SOX11 gene on SOX11 expression in the nasopharyngeal carcinoma and chronic inflammation tissues. The nasopharyngeal carcinoma cell line (CNE2) was treated with 5-aza-2'-deoxycytidine. The effect of promoter methylation of SOX11 on growth and invasion of nasopharyngeal carcinoma cells was detected with MTT test and Boyden chamber Matrigel invasion assay.

Results

No or weak expression of SOX11 mRNA was detected in the nasopharyngeal carcinoma tissues of SOX11 gene promoter methylation. Strong expression of SOX11 mRNA was detected in the nasopharyngeal carcinoma tissues of SOX11 gene promoter unmethylation and chronic inflammation tissues of pharynx nasalis. SOX11 mRNA and protein were re-expressed, SOX11 gene was demethylated, and growth and invasion of cells were inhibited in CNE2 cell line after 5-aza-2'-deoxycytidine treatment.

Conclusions

The results of the study indicate that expression of SOX11 mRNA and protein were related to SOX11 gene methylation status. SOX11 gene methylation may be plays a role in growth and invasion of nasopharyngeal carcinoma cells.
Appendix
Available only for authorised users
Literature
1.
Razin A, Riggs AD: DNA methylation and gene function. Science. 1980, 210: 604-610. 10.1126/science.6254144.CrossRefPubMed
2.
Bird AP: CpG-rich islands and the function of DNA Bird methylation. Nature. 1986, 321: 209-213. 10.1038/321209a0.CrossRefPubMed
3.
Esteller M, Silva JM, Dominguez G: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000, 92: 564-569. 10.1093/jnci/92.7.564.CrossRefPubMed
4.
Hiltunen MO, Alhonen L, Koistinaho J: Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer. 1997, 70: 644-648. 10.1002/(SICI)1097-0215(19970317)70:6<644::AID-IJC3>3.0.CO;2-V.CrossRefPubMed
5.
Herman JG, Umar A, Polyak K: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA. 1998, 95: 6870-6875. 10.1073/pnas.95.12.6870.PubMedCentralCrossRefPubMed
6.
Yoshiura K, Kanai Y, Ochiai A: Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA. 1995, 92: 7416-7419. 10.1073/pnas.92.16.7416.PubMedCentralCrossRefPubMed
7.
Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B: Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol. 2007, 39: 2195-2214. 10.1016/j.biocel.2007.05.019.PubMedCentralCrossRefPubMed
8.
Schepers GE, Teasdale RD, Koopman P: Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell. 2002, 3: 167-170. 10.1016/S1534-5807(02)00223-X.CrossRefPubMed
9.
Haslinger A, Schwarz TJ, Covic M, Chichung Lie D: Expression of Sox11 in adult neurogenic niches suggests a stage-specific role in adult neurogenesis. Eur J Neurosci. 2009, 29: 2103-2114.CrossRefPubMed
10.
Jankowski MP, Cornuet PK, McIlwrath S, Koerber HR, Albers KM: SRY-box containing gene 11 (SOX11) transcription factor is required for neuron survival and neurite growth. Neuroscience. 2006, 143: 501-514. 10.1016/j.neuroscience.2006.09.010.PubMedCentralCrossRefPubMed
11.
Weigle B, Ebner R, Temme A, Schwind S, Schmitz M: Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncol Rep. 2005, 13: 139-144.PubMed
12.
Brennan DJ, Ek S, Doyle E, Drew T, Foley M: The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer. 2009, 45: 1510-1517. 10.1016/j.ejca.2009.01.028.CrossRefPubMed
13.
Vegliante MC, Royo C, Palomero J, Salaverria I, Balint B: Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications. PLoS ONE. 2011, 6 (6): e21382-10.1371/journal.pone.0021382.PubMedCentralCrossRefPubMed
14.
Jay P, Goze C, Marsollier C, Taviaux S, Hardelin JP: The human SOX11 gene: cloning, chromosomal assignment and tissue expression. Genomics. 1995, 29: 541-545. 10.1006/geno.1995.9970.CrossRefPubMed
15.
Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C: Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt’s lymphoma. Haematologica. 2009, 94: 1563-1568. 10.3324/haematol.2009.008474.PubMedCentralCrossRefPubMed
16.
Hide T, Takezaki T, Nakatani Y, Nakamura H, Kuratsu J, Kondo T: SOX11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation. Cancer Res. 2009, 69: 7953-7959. 10.1158/0008-5472.CAN-09-2006.CrossRefPubMed
17.
Gustavsson E, Sernbo S, Andersson E, Brennan DJ, Dictor M, Jerkeman M, Borrebaeck CA, Sara EK: SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer. 2010, 9: 187-10.1186/1476-4598-9-187.PubMedCentralCrossRefPubMed
18.
Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002, 3: 415-428.CrossRefPubMed
19.
Siemens H, Neumann J, Jackstadt R, Mansmann U, Horst D, Kirchner T, Hermeking H: Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer. Clin Cancer Res. 2013, 19 (3): 710-720. 10.1158/1078-0432.CCR-12-1703. 1CrossRefPubMed
20.
Ozdemir F, Altinisik J, Karateke A, Coksuer H, Buyru N: Methylation of tumor suppressor genes in ovarian cancer. Exp Ther Med. 2012, 4 (6): 1092-1096.PubMedCentralPubMed
21.
Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO: Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin Cancer Res. 2005, 11: 5365-5369. 10.1158/1078-0432.CCR-04-2455.CrossRefPubMed
22.
Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M: DNA methylation is a reversible biological signal. Proc Natl Acad Sci USA. 1999, 96: 6107-6112. 10.1073/pnas.96.11.6107.PubMedCentralCrossRefPubMed
23.
Lyko F, Brown R: DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst. 2005, 97: 1498-1506. 10.1093/jnci/dji311.CrossRefPubMed
24.
Kong WJ, Zhang S, Guo CK, Wang YJ, Chen X, Zhang SL: Effect of methylation-associated silencing of the deathassociated protein kinase gene on nasopharyngeal carcinoma. Anticancer Drugs. 2006, 17: 251-259. 10.1097/00001813-200603000-00003.CrossRefPubMed
25.
Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D: Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Laryngoscope. 2005, 115: 1395-1401. 10.1097/01.MLG.0000166708.23673.3A.CrossRefPubMed
Metadata
Title
Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma
Authors
Song Zhang
Shuo Li
Jin-Liang Gao
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2013
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-13-109

Other articles of this Issue 1/2013

Cancer Cell International 1/2013 Go to the issue

Primary research

RETRACTED ARTICLE: Diagnosis, classification and grading of canine mammary tumours as a model to study human breast cancer: an Clinico-Cytohistopathological study with environmental factors influencing public health and medicine

Primary research

Beclin1 inhibition promotes autophagy and decreases gemcitabine–induced apoptosis in Miapaca2 pancreatic cancer cells

Primary research

Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line

Primary research

Hydrogen peroxide (H2O2) induces leukemic but not normal hematopoietic cell death in a dose-dependent manner

Primary research

Expression pattern of the apoptosis-stimulating protein of p53 family in p53+ human breast cancer cell lines

Primary research

Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits